PharmaForceIQ, a Boston, MA- and Orlando, FL-based provider of AI-driven, precision omnichannel orchestration and measurement solutions to pharmaceutical and life science companies, received a growth investment from Eir Partners.
The amount of the deal was not disclosed.
The company intends to use the funds to invest in product development, key team hires, and continued accumulation of data assets to enhance its HCP and DTC omnichannel offering.
PharmaForceIQ is an independent provider of precision omnichannel marketing solutions for the Life Science industry. The company uses a proprietary set of machine learning technologies to offer real time omnichannel deployment and measurement in the moments that matter most across commercial, medical and market access teams. The system prioritizes privacy and compliance. Brand managers use it to target their customers, and to deliver the right message at the right time across digital/personal promotion/peer-to-peer channels for healthcare provider (HCP) and direct to consumer (DTC) audiences driving enhanced ROI in terms of Rx and Revenue Lift.
FinSMEs
12/09/2024